{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:20:31Z","timestamp":1789698031936,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024ZD0533203"],"award-info":[{"award-number":["2024ZD0533203"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC3602300"],"award-info":[{"award-number":["2022YFC3602300"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC3602302"],"award-info":[{"award-number":["2022YFC3602302"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024ZD0533200"],"award-info":[{"award-number":["2024ZD0533200"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004717","name":"Ministry of National Defense of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eprac.2025.12.017","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T07:47:51Z","timestamp":1767080871000},"page":"894-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Quantification of Cortisol and Dexamethasone Establishes a Platform-Specific Dexamethasone Lower Limit and Improves Diagnostic Specificity of the 1-mg Overnight Dexamethasone Suppression Test"],"prefix":"10.1016","volume":"32","author":[{"given":"Yumeng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-5078","authenticated-orcid":false,"given":"Xinqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eprac.2025.12.017_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13111","article-title":"Diagnostic workup of Cushing's syndrome","volume":"34","author":"Balomenaki","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.017_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JU.0000000000003644","article-title":"Diagnosis, management, and Follow-Up of the incidentally discovered adrenal mass: CUA guideline endorsed by the AUA","volume":"210","author":"Rowe","year":"2023","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.017_bib3","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the study of Adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.017_bib4","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.017_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/a-1017-3217","article-title":"Factors affecting dexamethasone suppression test results","volume":"128","author":"Berli\u0144ska","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.017_bib6","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1210\/clinem\/dgab724","article-title":"Interpretation of abnormal dexamethasone suppression test is enhanced with use of synchronous free cortisol assessment","volume":"107","author":"Genere","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.017_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/clinchem\/hvab056","article-title":"Method-specific cortisol and dexamethasone thresholds increase clinical specificity of the dexamethasone suppression test for cushing syndrome","volume":"67","author":"Vogg","year":"2021","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.eprac.2025.12.017_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","article-title":"Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation","volume":"43","author":"Ceccato","year":"2020","journal-title":"J Endocrinological Invest"},{"issue":"7486","key":"10.1016\/j.eprac.2025.12.017_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.330.7486.299","article-title":"Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome","volume":"330","author":"Ma","year":"2005","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.017_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkab412","article-title":"Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIV","volume":"77","author":"Jacobs","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.017_bib11","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1210\/jc.2018-00352","article-title":"Glucocorticoid receptor mutations and hypersensitivity to endogenous and exogenous glucocorticoids","volume":"103","author":"Santen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.017_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41572-024-00588-w","article-title":"Cushing syndrome","volume":"11","author":"Nieman","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.017_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.017_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0004563219870834","article-title":"Retrospective analysis of repeated dexamethasone suppression tests - the added value of measuring dexamethasone","volume":"56","author":"de Graaf","year":"2019","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.017_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-2952(97)00166-4","article-title":"In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies","volume":"54","author":"Tomlinson","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.017_bib16","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/cts.12970","article-title":"Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4\u22171G allele function","volume":"14","author":"Fohner","year":"2021","journal-title":"Clin Transl Sci"},{"issue":"8","key":"10.1016\/j.eprac.2025.12.017_bib17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1124\/dmd.107.020065","article-title":"The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans","volume":"36","author":"Roberts","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.017_bib18","first-page":"315","article-title":"Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy","volume":"75","author":"Kyriazopoulou","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.017_bib19","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the study of Adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.017_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40618-017-0644-8","article-title":"First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS\/MS","volume":"40","author":"Ceccato","year":"2017","journal-title":"J Endocrinological Invest"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.017_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","article-title":"Prevalence of functioning adrenal Incidentalomas: a systematic review and meta-analysis","volume":"108","author":"Sconfienza","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.017_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s42000-021-00308-z","article-title":"Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas","volume":"20","author":"Araujo-Castro","year":"2021","journal-title":"Hormones (Athens, Greece)"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.017_bib23","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1210\/jc.2002-021778","article-title":"Troglitazone induces CYP3A4 activity leading to falsely abnormal dexamethasone suppression test","volume":"88","author":"Dimaraki","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.12.017_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1143835","article-title":"Age-related modifications in CYP-dependent drug metabolism: role of stress","volume":"14","author":"Konstandi","year":"2023","journal-title":"Front Endocrinol"},{"issue":"22","key":"10.1016\/j.eprac.2025.12.017_bib25","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.3390\/jcm12227120","article-title":"Drug-drug interactions involving dexamethasone in clinical practice: myth or reality?","volume":"12","author":"Bourdin","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.017_bib26","first-page":"CD008165","article-title":"Interventions to improve the appropriate use of polypharmacy for older people","volume":"10","author":"Cole","year":"2023","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:27:39Z","timestamp":1781018859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25013461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1530891X25013461"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.017","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Quantification of Cortisol and Dexamethasone Establishes a Platform-Specific Dexamethasone Lower Limit and Improves Diagnostic Specificity of the 1-mg Overnight Dexamethasone Suppression Test","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}